Key result
Plin5-S155A overexpression reduces cardiac fatty acid oxidation and mitochondrial fission while preserving cardiac function in mice.
Why the study?
Lipotoxic cardiomyopathy involves increased cardiac fatty acid uptake exceeding mitochondrial oxidative capacity, and the therapeutic potential of lowering cardiac lipolysis to prevent lipotoxic heart dysfunction remains unclear due to conflicting effects of defective TAG catabolism.
Does low cardiac lipolysis via Plin5-S155A overexpression prevent lipotoxic heart dysfunction in mice?
Does low cardiac lipolysis via Plin5-S155A overexpression prevent lipotoxic heart dysfunction in mice?
Low cardiac lipolysis via Plin5 mutation reduces mitochondrial fission and preserves heart function despite lipid accumulation, suggesting a potential strategy against lipotoxic cardiomyopathy.
Hypothesis-generating for Plin5 modulation in lipotoxic cardiomyopathy; leaves open translation to human heart failure.
AIMS: Lipotoxic cardiomyopathy in diabetic and obese patients typically encompasses increased cardiac fatty acid (FA) uptake eventually surpassing the mitochondrial oxidative capacity. Lowering FA utilization via inhibition of lipolysis represents a strategy to counteract the development of lipotoxic heart dysfunction. However, defective cardiac triacylglycerol (TAG) catabolism and FA oxidation in humans (and mice) carrying mutated ATGL alleles provokes lipotoxic heart dysfunction questioning a therapeutic approach to decrease cardiac lipolysis. Interestingly, decreased lipolysis via cardiac overexpression of Perilipin 5 (Plin5), a binding partner of ATGL, is compatible with normal heart function and lifespan despite massive cardiac lipid accumulation. Herein, we decipher mechanisms that protect Plin5 transgenic mice from the development of heart dysfunction. METHODS AND RESULTS: We generated mice with cardiac-specific overexpression of Plin5 encoding a serine-155 to alanine exchange (Plin5-S155A) of the protein kinase A phosphorylation site, which has been suggested as a prerequisite to stimulate lipolysis and may play a crucial role in the preservation of heart function. Plin5-S155A mice showed a substantial increase in cardiac TAG and ceramide levels, which was comparable to mice overexpressing non-mutated Plin5. Lipid accumulation was compatible with normal heart function even under mild stress. Plin5-S155A mice showed reduced cardiac FA oxidation but normal ATP production and changes in the Plin5-S155A phosphoproteome compared to Plin5 transgenic mice. Interestingly, mitochondrial recruitment of dynamin-related protein 1 (Drp1) was markedly reduced in cardiac muscle of Plin5-S155A and Plin5 transgenic mice accompanied by decreased phosphorylation of mitochondrial fission factor, a mitochondrial receptor of Drp1. CONCLUSIONS: This study suggests that low cardiac lipolysis is associated with reduced mitochondrial fission and may represent a strategy to combat the development of lipotoxic heart dysfunction.
No takes yet. Share an insight, caveat, or question.
Kolleritsch et al. (2019) studied Lipotoxic cardiomyopathy. Cardiac-specific overexpression of Plin5-S155A vs. Plin5 transgenic mice (overexpressing non-mutated Plin5) was evaluated on Cardiac TAG and ceramide levels, heart function, FA oxidation, ATP production, and mitochondrial fission. Cardiac-specific overexpression of Plin5-S155A in mice reduced cardiac fatty acid oxidation and mitochondrial fission while preserving normal heart function despite lipid accumulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: